Matches in Nanopublications for { ?s ?p "DDI between Bexarotene and Tigecycline - Tigecycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. The development of pseudotumor cerebri (intracranial hypertension) is of particular concern. Avoid this combination. [drugbank_resource:DB00307_DB00560]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00307_DB00560 label "DDI between Bexarotene and Tigecycline - Tigecycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. The development of pseudotumor cerebri (intracranial hypertension) is of particular concern. Avoid this combination. [drugbank_resource:DB00307_DB00560]" assertion.